Blinatumomab to improve the outcome of children with relapsed B-cell acute lymphoblastic leukemia.
Jose-Luis FusterF BautistaB GonzálezJ M FernándezS RivesJ L Dapenanull nullPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)